117 related articles for article (PubMed ID: 330766)
1. Radiographic measurement of topical corticosteroid-induced atrophy.
Snyder DS; Greenberg RA
J Invest Dermatol; 1977 Sep; 69(3):279-81. PubMed ID: 330766
[TBL] [Abstract][Full Text] [Related]
2. Measurement of skin thickness: a comparison of two in vivo techniques with a conventional histometric method.
Dykes PJ; Marks R
J Invest Dermatol; 1977 Sep; 69(3):275-8. PubMed ID: 894062
[TBL] [Abstract][Full Text] [Related]
3. A study of potential skin atrophy following topical application of weak corticosteroids.
Black MM; Platt NE; Mugglestone CJ
Curr Med Res Opin; 1981; 7(7):463-70. PubMed ID: 7261664
[TBL] [Abstract][Full Text] [Related]
4. The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study.
Queille-Roussel C; Paul C; Duteil L; Lefebvre MC; Rapatz G; Zagula M; Ortonne JP
Br J Dermatol; 2001 Mar; 144(3):507-13. PubMed ID: 11260007
[TBL] [Abstract][Full Text] [Related]
5. Comparative atrophogenicity potential of medium and highly potent topical glucocorticoids in cream and ointment according to ultrasound analysis.
Kerscher MJ; Korting HC
Skin Pharmacol; 1992; 5(2):77-80. PubMed ID: 1637562
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial.
Cossmann M; Welzel J
Br J Dermatol; 2006 Oct; 155(4):700-6. PubMed ID: 16965418
[TBL] [Abstract][Full Text] [Related]
7. Methods for the assessment of skin atrophogenicity of topical corticosteroids.
Marks R
Dermatologica; 1976; 152 Suppl 1():117-26. PubMed ID: 133834
[TBL] [Abstract][Full Text] [Related]
8. Improved risk-benefit ratio for topical triamcinolone acetonide in Transfersome in comparison with equipotent cream and ointment: a randomized controlled trial.
Fesq H; Lehmann J; Kontny A; Erdmann I; Theiling K; Rother M; Ring J; Cevc G; Abeck D
Br J Dermatol; 2003 Sep; 149(3):611-9. PubMed ID: 14510997
[TBL] [Abstract][Full Text] [Related]
9. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
Serup J; Holm P
Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of bufexamac (NFN) cream in skin diseases. A double-blind multicentre trial.
Christiansen JV; Gadborg E; Kleiter I; Ludvigsen K; Meier CH; Norholm A; Reiter H; Reymann F; Raaschou-Nielsen W; Sondergaard M; Unna P; Wehnert R
Dermatologica; 1977; 154(3):177-84. PubMed ID: 140084
[TBL] [Abstract][Full Text] [Related]
11. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
[TBL] [Abstract][Full Text] [Related]
12. Clinical experiences with hydrocortisone 17-butyrate.
Yasuda T
Dermatologica; 1976; 152 Suppl 1():221-9. PubMed ID: 782956
[TBL] [Abstract][Full Text] [Related]
13. The kinetics of skin thinning induced by topical fluticasone propionate 0.05% cream in volunteer subjects.
Dykes PJ; Marks R; Hill S; Mills C; Eastwood R
Clin Exp Dermatol; 1996 May; 21(3):180-4. PubMed ID: 8914356
[TBL] [Abstract][Full Text] [Related]
14. A comparison of triamcinolone acetonide MDI with a built-in tube extender and beclomethasone dipropionate MDI in adult asthmatics.
Berkowitz R; Rachelefsky G; Harris AG; Chen R
Chest; 1998 Sep; 114(3):757-65. PubMed ID: 9743163
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroid-induced dermal atrophy in the rat.
Young JM; Yoxall BE; Wagner BM
J Invest Dermatol; 1977 Nov; 69(5):458-62. PubMed ID: 908845
[TBL] [Abstract][Full Text] [Related]
16. Ultrasonic assessment of cutaneous atrophy caused by intradermal corticosteroids.
Gomez EC; Berman B; Miller DL
J Dermatol Surg Oncol; 1982 Dec; 8(12):1071-4. PubMed ID: 7153406
[TBL] [Abstract][Full Text] [Related]
17. [Reducing the dosage by new technology].
Steinhorst M
Hautarzt; 2001 Jan; 52(1):p following 90 (91). PubMed ID: 11220248
[No Abstract] [Full Text] [Related]
18. Comparison of skin atrophy and vasoconstriction due to mometasone furoate, methylprednisolone and hydrocortisone.
Hoffmann K; Auer T; Stücker M; Hoffmann A; Altmeyer P
J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):137-42. PubMed ID: 9553910
[TBL] [Abstract][Full Text] [Related]
19. Measurement of dermal atrophy induced by topical steroids using a radiographic technique.
James MP; Black MM; Sparkes CG
Br J Dermatol; 1977 Mar; 96(3):303-5. PubMed ID: 322693
[TBL] [Abstract][Full Text] [Related]
20. Assessment of atrophogenicity of popularly prescribed topical corticosteroids.
Dykes PJ; Marks R; Blakemore CB
Br J Clin Pract; 1978 Dec; 32(12):345-8. PubMed ID: 737113
[No Abstract] [Full Text] [Related]
[Next] [New Search]
